Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP

Journal of Biomedical Research

Volumn 29, Issue 3, 2015, Pages 176-188

  Yokoyama, Shinji ^a   Okumura Noji, Kuniko ^a   Lu, Rui ^a  

^a CHUBU UNIVERSITY   (Japan)

Author keywords

CETP deficiency; Cholesteryl ester; Granulomatosis; HDL; Liver cirrhosis; Schistosoma japonicum

Indexed keywords

AMINO ACID; ANTIBODY; CD36 RELATED PROTEIN; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ASIA; CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY; CLINICAL FEATURE; DRUG TARGETING; EGG YOLK; EMBRYO DEVELOPMENT; ENDEMIC DISEASE; GENE MUTATION; HUMAN; LIVER CIRRHOSIS; LIVER GRANULOMA; MIRACIDIUM; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN SYNTHESIS INHIBITION; REVIEW; RUSSIAN FEDERATION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

EID: 84932141321     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.29.20150005     Document Type: Review

References (84)

1. Iida F, Iida R, Kamijo H, et al. Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan[J]. Bull World Health Organ, 1999,77(7):573-581.
2. McManus DP, Gray DJ, Li Y, et al. Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam[J]. Clin Microbiol Rev, 2010,23(2):442-466.
3. Wang LD, Chen HG, Guo JG, et al. A strategy to control transmission of Schistosoma japonicum in China[J]. N Engl J Med, 2009,360(2):121-128.
4. Bergquist R, Tanner M. Controlling schistosomiasis in Southeast Asia: a tale of two countries[J]. Adv Parasitol, 2010,72:109-144.
5. Gordon CA, Acosta LP, Gray DJ, et al. High prevalence of Schistosoma japonicum infection in Carabao from Samar Province, the Philippines: implications for transmission and control[J]. PLoS Negl Trop Dis, 2012,6(9):e1778.
6. Harinasuta C. Epidemiology and control of schistosomiasis in Southeast Asia[J]. Southeast Asian J Trop Med Public Health, 1984,15(4):431-438.
7. Ross AGP, Bartley PB, Sleigh AC, et al. Schistosomiasis[J]. New Eng J Med, 2002,346(16):1212-1220.
8. Mohda J, Redman CA, Thormhill JA, et al. Schstosomes: Unanswered questions on the basic biology of the hostparasite relationship[J]. Prasitol Today, 1998,14(10): 396-401.
9. Hirata M, Takushima M, Kaga M, et al. Induction of experimental murine granuloma formation against Schistosoma japonicum eggs produced by in vitro ova deposition, in vitro tissue extraction, or lyophilization[J]. Parasitol Res, 1991,77(4):315-319.
10. El Ridi R, Velupillai P, Harn DA. Regulation of Schistosome egg granuloma formation: Host-soluble l-selectin enters tissue-trapped eggs and binds to carbohydrate antigens on surface membrane of miracidia[J]. Infect Immun, 1996,64(11): 4700-4705.
11. Mitchell G, Garcia EG, Rivera PT, et al. Evidence for and implications of anti-embryonation immunity in Schistosomiasis[J]. Exper Parasitol, 1994,79(4):546-549.
12. Rumjanek FD, Campos EG, Afonso LC. Evidence for the occurrence of LDL receptors in extracts of schistosomula of Schistosoma mansoni[J]. Mol Biochem Parasitol, 1988,28(2):145-152.
13. Rumjanek FD, McLaren DJ, Smithers SR. Serum-induced expression of a surface protein in schistosomula of Schistosoma mansoni: a possible receptor for lipid uptake[J]. Mol Biochem Parasitol, 1983,9(4):337-350.
14. Xu X, Caulfield JP. Characterization of human low density lipoprotein binding proteins on the surface of Schistosomula of Schistosoma mansoni[J]. Eur J Cell Biol, 1992,57(2):229-235.
15. Furlong ST, Thibault KS, Morbelli LM, et al. Uptake and compartmentalization of fluorescent lipid analogs in larval Schistosoma mansoni[J]. J Lipid Res, 1995,36(1):1-12.
16. Rogers MV, Quilici D, Mitchell GF, et al. Purification of a putative lipoprotein receptor from Schistosoma japonicum adult worms[J]. Mol Biochem Parasitol, 1990,41(1):93-100.
17. Fan J, Xiaoxian G, Yang W, et al. A Schistosoma japonicum very low-density lipoprotein-binding protein[J]. Int J Biochem Cell Biol, 2003,35(10):1436-1451.
18. Okumura-Noji K, Sasai K, Zhan R, et al. Cholesteryl ester transfer protein deficiency causes slow egg embryonation of Schistosoma japonicum[J]. Biochem Biophys Res Com, 2001,286(2):305-310.
19. Okumura-Noji K, Miura Y, Lu R, et al. CD36-related protein in Schistosoma japonicum: candidate mediator of selective cholesteryl ester uptake from high-density lipoprotein for egg maturation[J]. FASEB J, 2013, 27(3):1236-1244.
20. Yokoyama S. A potential screening factor for accumulation of cholesteyl ester transfer protein deficiency in East Asia: Schistosoma japonicum[J]. Biochim Biophys Acta, 2014,1841(4):495-504.
21. Bruce C, Davidson WS, Kussie P, et al. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins[J]. J Biol Chem, 1995,270(19): 11532-11542.
22. Jiang XC, Bruce C, Cocke T, et al. Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/ lipopolysaccharide binding protein gene family essential for function[J]. Biochemistry, 1995,34(21):7258-7263.
23. Tall A. Plasma lipid transfer proteins[J]. Ann Rev Biochem, 1995,64:235-257.
24. Wang S, Kussie P, Deng L, et al. Defective binding of neutral lipids by carboxyl-terminal deletion mutant of cholesteryl ester transfer protein[J]. J Biol Chem, 1995, 270(2):612-618.
25. Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA[J]. Nature, 1987,327(6123):632-634.
26. Ko KW, Ohnishi T, Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies[J]. J Biol Chem, 1994,269(45):28206-28213.
27. Ohnishi T, Hicks LD, Oikawa K, et al. Properties of human plasma lipid transfer protein in aqueous solution and at interfaces[J]. Biochemistry, 1994,33(20):6093-6099.
28. Ohnishi T, Tan C, Yokoyama S. Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsion[J]. Biochemistry, 1994,33:4533-4542.
29. Qiu X, Mistry A, Ammirati MJ, et al. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules[J]. Nat Struct Mol Biol, 2007, 14(2):106-113.
30. Foger B, Ritsch A, Doblinger A, et al. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia[J]. Arterioscler Thromb Vasc Biol, 1996,16(12):1430-1436.
31. Czarnecka H, Yokoyama S. Regulation of lecithin-cholesterol acyltransferase reaction by acyl acceptors and demonstration of its "idling"reaction[J]. J Biol Chem, 1993,268(26):19334-19340.
32. Francis GA, Ko KW, Hara H, et al. Regulation of the uptake of high-density lipoprotein-originated cholesteryl ester by HepG2 cells: role of low-density lipoprotein and plasma lipid transfer protein[J]. Biochim Biophys Acta, 1991,1084(2):159-166.
33. Kurasawa T, Yokoyama S, Miyake Y, et al. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia[J]. J Biochem, 1985,98(6):1499-1508.
34. Koizumi J, Mabuchi H, Yoshimura A, et al. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia[J]. Atheroscler, 1985,58(1-3):175-186.
35. Brown ML, Inazu A, Hesler CB, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins[J]. Nature, 1989,342(6248): 448-451.
36. Inazu A, Jiang XC, Haraki T, et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol[J]. J Clin Invest, 1994,94(5):1872-1882.
37. Sakai N, Yamashita S, Hirano K, et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects[J]. Atherosclerosis, 1995,114(2):139-145.
38. Hirano K, Yamashita S, Nakajima N, et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity[J]. Arterioscler Thromb Vasc Biol, 1997, 17(6):1053-1059.
39. Maruyama T, Yamashita S, Matsuzawa Y, et al. Mutations in Japanese subjects with primary hyperlipidemia-results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996[J]. J Atheroscler Thromb, 2004,11(3):131-145.
40. Yamashita S, Hirano K, Sakai N, et al. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein[J]. Biochim Biophys Acta, 2000, 1529(1-3):257-275.
41. Nagano M, Yamashita S, Hirano K, et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese[J]. J Atheroscler Thromb, 2004, 11(3):110-121.
42. Nagano M, Yamashita S, Hirano K, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay[J]. J Lipid Res, 2002,43(7):1011-1018.
43. Ritsch A, Drexel H, Amann FW, et al. Deficiency of cholesteryl ester transfer protein: Description of molecular defect and the dissociation of cholesteryl ester and triglyceride transfer in plasma[J]. Arterioscler Thromb Vasc Biol, 1997,17(16):3433-3441.
44. Chen DW, Yang JF, Tang Z, et al. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese[J]. Brain Res, 2008,1187:52-57.
45. Chiba H, Akita H, Tsuchihashi K, et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency[J]. J Lipid Res, 1997,38(6):1204-1216.
46. Hui S-P. Frequency and effect on plasma lipoprotein metabolism of a mutation in the cholesteryl ester transfer protein gene in the Chinese[J]. Hokkaido J Med Sci, 1997,72(3):319-327.
47. Hsu LA, Ko YL, Hsu KH, et al. Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese[J]. Hum Genet, 2002,110(1):57-63.
48. Jap TS, Wu YC, Tso YC, et al. A novel mutation in the intron 1 splice donor site of the cholesterol ester transfer protein (CETP) gene as a cause of hyperalphalipoproteinemia[J]. Metabolism, 2002,51(3):394-397.
49. Yang GJ, Gemperli A, Vounatsou P, et al. A growing degree-days based time-series analysis for prediction of Schistosoma japonicum transmission in Jiangsu province, China[J]. Am J Trop Med Hyg, 2006,75(3):549-555.
50. Song G-J, Han G-H, Chae J-J, et al. The effect of the cholesterol ester transfer protein gene and environmental factors on the plasma high density lipoprotein cholesterol levels in the Korean population[J]. Molecules & Cells, 1997,7(5):615-619.
51. Thu NN, Mai TT, Ohmori R, et al. Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children[J]. Pediatr Res, 2005,58(6):1249-1253.
52. Plengpanich W, Siriwong S, Khovidhunkit W. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia[J]. Metabolism, 2009,58(8):1178-1184.
53. Thompson JF, Reynolds JM, Williams SP, et al. Frequency and function of CETP variants among individuals of Asian ancestry[J]. Atherosclerosis, 2009,202(1):241-247.
54. Arkhipova NS, Ar'ev AL, Popova EK, et al. Association of polymorphism of angiotensin-converting enzyme gene I/D and D442G cholesteryl ester transfer protein gene with risk factors for atherosclerosis among elderly and senile patients with coronary heart disease in the Republic Sakha (Yakutia)[J]. Adv Gerontol, 2013,3(4): 277-281.
55. Finkelstein JL, Schleinitz MD, Carabin H, et al. Decisionmodel estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature[J]. PLoS Negl Trop Dis, 2008,2(3):e158.
56. Ma YQ, Thomas GN, Critchley JA, et al. Identification of the intron 14 splicing defect of the cholesteryl ester transfer protein gene in Hong Kong Chinese[J]. Clin Genet, 2001,59(4):287-289.
57. Nihei N, Kajihara N, Kirinoki M, et al. Establishment of a GIS monitoring system for schistosomiasis japonica in Kofu, Japan[J]. Ann Trop Med Parasitol, 2006, 100(2):143-153.
58. Takahashi H, Takahashi A, Maki M, et al. Effect of CETP on the plasma lipoprotein profile in four strains of transgenic mouse[J]. Biochem Biophys Res Commun, 2001,283(1): 118-123.
59. Zhang R, Yoshida A, Kumagai T, et al. Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum[J]. Infect Immun, 2001,69(1):386-391.
60. Teh EM, Dolphin PJ, Breckenridge WC, et al. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America[J]. J Lipid Res, 1998,39:442-456.
61. Hill SA, Nazir DJ, Jayaratne P, et al.Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population[J]. Clin Biochem, 1997,30(5):413-418.
62. van der Steeg WA, Hovingh GK, Klerkx AH, et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians[J]. J Lipid Res, 2007,48(3): 674-682.
63. Rhyne J, Ryan MJ, White C, et al. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease[J]. J Mol Med (Berl), 2006,84(8):647-650.
64. Cefalu AB, Noto D, Magnolo L, et al. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia[J]. Atherosclerosis, 2009,204(1):202-207.
65. Calabresi L, Nilsson P, Pinotti E, et al. A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred[J]. Atherosclerosis, 2009,205(2):506-511.
66. Chantepie S, Bochem AE, Chapman MJ, et al. Highdensity lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity[J]. PLoS One, 2012,7(11):e49336.
67. Thompson A, Di Angelantonio E, Sarwar N, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk[J]. JAMA, 2008,299(23):2777-2788.
68. Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation[J]. N Engl J Med, 1990,323(18):1234-1238.
69. Yamashita S, Sprecher DL, Sakai N, et al. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency[J]. J Clin Invest, 1990,86(3):688-695.
70. Sakai N, Matsuzawa Y, Hirano K, et al. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency[J]. Arterioscler Thromb, 1991,11(1):71-79.
71. Yamashita S, Hui DY, Wetterau JR, et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficeiency: Plasma CETP regulated high-density lipoprotein concentration and composition[J]. Metabolism, 1991,40(7): 756-763.
72. Moriyama Y, Okamura T, Inazu A, et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency[J]. Prev Med, 1998,27(5 Pt 1):659-667.
73. Curb JD, Abbott RD, Rodriguez BL, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly[J]. J Lipid Res, 2004,45(5):948-953.
74. Nissen SE, Tardif JC, Nicholls SJ, et al. Effect of torcetrapib on the progression of coronary atherosclerosis[J]. N Engl J Med, 2007,356(13):1304-1316.
75. Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome[J]. N Engl J Med, 2012,367(22):2089-2099.
76. Betard C, Kessling AM, Roy M, et al. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians[J]. Hum Genet, 1992,88(5): 529-536.
77. Torrington M, Botha JL, Pilcher GJ, et al. Association between familial hypercholesterolaemia and church affiliation. Is this the result of sociocultural isolation of migrant farmers in 19th-century South Africa?[J]. S Afr Med J, 1984,65(19):762-767.
78. Abifadel M, Rabes JP, Jambart S, et al. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene[J]. Hum Mutat, 2009,30(7):E682-691.
79. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection[J]. Br Med J, 1954,1(4857): 290-294.
80. Hedrick PW. Resistance to malaria in humans: the impact of strong, recent selection[J]. Malar J, 2012,11:349.
81. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis[J]. The Lancet Infectious Diseases, 2012,12(6):457-468.
82. Acton S, Gigotti A, Landschulz T, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor[J]. Science, 1996,271(5248):518-520.
83. Murao K, Terpstra V, Green SR, et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes[J]. J Biol Chem, 1997,272(28):17551-17557.
84. Okamoto H, Yonemori F, Wakitani K, et al. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits[J]. Nature, 2000,406(6792):203-207.